168 related articles for article (PubMed ID: 27685462)
1. Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.
Wergeland I; Assmus J; Dyrhol-Riise AM
PLoS One; 2016; 11(9):e0163848. PubMed ID: 27685462
[TBL] [Abstract][Full Text] [Related]
2. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
[TBL] [Abstract][Full Text] [Related]
3. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
[TBL] [Abstract][Full Text] [Related]
4. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
Akashi S; Suzukawa M; Takeda K; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect Chemother; 2021 Apr; 27(4):617-624. PubMed ID: 33317988
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers to identify
Uzorka JW; Bakker JA; van Meijgaarden KE; Leyten EMS; Delfos NM; Hetem DJ; Kerremans J; Zwarts M; Cozijn S; Ottenhoff THM; Joosten SA; Arend SM
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35058249
[TBL] [Abstract][Full Text] [Related]
6. Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study.
Zhang L; Yang Z; Wu F; Ge Q; Zhang Y; Li D; Gao M; Liu X
BMC Infect Dis; 2024 Jan; 24(1):28. PubMed ID: 38166667
[TBL] [Abstract][Full Text] [Related]
7. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
12. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Suzukawa M; Takeda K; Akashi S; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect; 2020 May; 80(5):547-553. PubMed ID: 32092390
[TBL] [Abstract][Full Text] [Related]
14. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
15. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
[TBL] [Abstract][Full Text] [Related]
16. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
[TBL] [Abstract][Full Text] [Related]
17. Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection.
Petruccioli E; Vanini V; Chiacchio T; Cirillo DM; Palmieri F; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S143-S144. PubMed ID: 28043514
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
19. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
20. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
